Exclusion of overlapping symptoms in DSM-5 mixed features specifier: Heuristic diagnostic and treatment implications

CNS Spectrums

Volumn 22, Issue 2, 2017, Pages 126-133

  Malhi, Gin S ^a,b,c   Byrow, Yulisha ^a,b,c   Outhred, Tim ^a,b,c   Fritz, Kristina ^a,b,c  

^a St George Hospital and Community Health Service   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Agitated depression; bipolar disorder; depression; DSM 5; mixed features; mixed mania; mixed states

Indexed keywords

FLUOXETINE PLUS OLANZAPINE; LURASIDONE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; VALPROIC ACID; ANTIDEPRESSANT AGENT; LITHIUM CARBONATE;

ANXIETY DISORDER; BIPOLAR DISORDER; DEPRESSION; DISEASE CLASSIFICATION; DISEASES; DISTRACTIBILITY; DSM-5; HUMAN; IRRITABILITY; KRAEPELIN ORIGINAL CLASSIFICATION; MAJOR DEPRESSION; MANIA; MIXED FEATURES SPECIFIER; MONOTHERAPY; OVERLAPPING SYMPTOM; RESTLESSNESS; REVIEW; SYMPTOM; ANXIETY DISORDERS; CLASSIFICATION; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; PSYCHOLOGY; RESEARCH; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; LITHIUM CARBONATE; RESEARCH; TREATMENT OUTCOME;

EID: 84996671322     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852916000614     Document Type: Review

References (44)

1. Kraepelin E. Clinical psychiatry: a text-book for students and physicians, New York: Macmillan; 1904.
2. Diefendorf RA. IX. Manic-depressive insanity. In: Clinical Psychiatry: A Textbook for Students and Physicians, Abstracted and Adapted from the 7th German Edition of Kraepelin?s Lehrbuch Der Psychiatrie. 7th ed. New York: Macmillan & Co.; 1907: 381-422.
3. Maina G, Bertetto N, Boccolini FD, Di Salvo G, Rosso G, Bogetto F. The concept of mixed state in bipolar disorder: from Kraepelin to DSM-5. Journal of Psychopathology. 2013; 19: 287-295.
4. Trede K, Salvatore P, Baethge C, Gerhard A, Maggini C, Baldessarini RJ. Manic-depressive illness: evolution in Kraepelin?s Textbook, 1883-1926. Harv Rev Psychiatry. 2005; 13(3): 155-178.
5. Marneros A. Origin and development of concepts of bipolar mixed states. J Affect Disord. 2001; 67(1-3): 229-240.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev.Washington, DC: American Psychiatric Association; 1987.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed rev.Washington, DC: American Psychiatric Association; 2000.
10. Faedda GL, Marangoni C, Reginaldi D. Depressive mixed states: a reappraisal of Koukopoulos?criteria. J Affect Disord. 2015; 176: 18-23.
11. Akiskal HS, Hantouche EG, Bourgeois ML, et al. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord. 1998; 50(2-3): 175-186.
12. Perugi G, Akiskal HS, Micheli C, et al. Clinical subtypes of bipolar mixed states. J Affect Disord. 1997; 43(3): 169-180.
13. Benazzi F. Age at onset of bipolar II depressive mixed state. Psychiatry Res. 2001; 103(2-3): 229-235.
14. Koukopoulos A, Koukopoulos A. Agitated depression as a mixed state and the problem of melancholia. Psychiatr Clin North Am. 1999; 22(3): 547-564.
15. Koukopoulos A, Sani G, Ghaemi SN. Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV). Br J Psychiatry. 2013; 203(1): 3-5.
16. Koukopoulos A, Sani G. DSM-5 criteria for depression with mixed features: a farewell to mixed depression. Acta Psychiatr Scand. 2014; 129(1): 4-16.
17. Koukopoulos A, Sani G, Koukopoulos A, Manfredi G, Pacchiarotti I, Girardi P. Melancholia agitata and mixed depression. Acta Psychiatr Scand Suppl. 2007; (433): 50-57.
18. McIntyre RS, Soczynska JK, Cha DS, et al. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: results from the International Mood Disorders Collaborative Project. J Affect Disord. 2015; 172: 259-264.
19. Harrison PJ, Cipriani A, Harmer CJ, et al. Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci. 2016; 1366(1): 76-89.
20. Cassidy F, Yatham LN, Berk M, Grof P. Pure and mixed manic subtypes: a review of diagnostic classification and validation. Bipolar Disord. 2008; 10(1 Pt 2): 131-143.
21. Perugi G, Angst J, Azorin J-M, et al.Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry. 2015; 76(3): e351-e358.
22. Judd LL, Schettler PJ, Akiskal H, et al. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. J Affect Disord. 2012; 138(3): 440-448.
23. Pae CU, Vohringer PA, Holtzman NS, et al. Mixed depression: a study of its phenomenology and relation to treatment response. J Affect Disord. 2012; 136(3): 1059-1061.
24. Targum SD, Suppes T, Pendergrass JC, et al. Major depressive disorder with subthreshold hypomania (mixed features): clinical characteristics of patients entered in a multiregional, placebocontrolled study. Prog Neuropsychopharmacol Biol Psychiatry. 2016; 68: 9-14.
25. Miller S, Suppes T, Mintz J, et al. Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow-up in the Stanley Bipolar Network. Am J Psychiatry. In press. doi: 10.1176/appi.ajp.2016.15091119.
26. Malhi GS, Fritz K, Allwang C, et al. Agitation for recognition by DSM-5 mixed features specifier signals fatigue?. Aust N Z J Psychiatry. 2015; 49(6): 499-501.
27. Cassidy F, Ahearn E, Carroll BJ. Concordance of self-rated and observer-rated dysphoric symptoms in mania. J Affect Disord. 2009; 114(1-3): 294-298.
28. Cassidy F. Anxiety as a symptom of mixed mania: implications for DSM-5. Bipolar Disord. 2010; 12(4): 437-439.
29. Swann AC, Steinberg JL, Lijffijt M, Moeller GF. Continuum of depressive and manic mixed states in patients with bipolar disorder: quantitative measurement and clinical features. World Psychiatry. 2009; 8(3): 166-172.
30. Sato T, Bottlender R, Kleindienst N, Möller HJ. Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry. 2002; 159(6): 968-974.
31. Malhi GS, Fritz K, Allwang C, et al. Are manic symptoms that "dip" into depression the essence of mixed features?. J Affect Disord. 2016; 192: 104-108.
32. Malhi GS, Masson M, Bellivier F. Teasing apart bipolar III: the causes and consequences of a treatment-emergent affective switch (TEAS) into mania. Aust N Z J Psychiatry. 2015; 49(10): 866-868.
33. Perugi G, Medda P, Reis J, Rizzato S, Giorgi Mariani M, Mauri M. Clinical subtypes of severe bipolar mixed states. J Affect Disord. 2013; 151(3): 1076-1082.
34. Perugi G, Medda P, Swann AC, Reis J, Rizzato S, Mauri M. Phenomenological subtypes of severe bipolar mixed states: a factor analytic study. Compr Psychiatry. 2014; 55(4): 799-806.
35. Fornaro M, Stubbs B, De Berardis D, et al. Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: a systematic review and exploratory meta-Analysis of placebocontrolled clinical trials. Int J Mol Sci. 2016; 17(2): 241.
36. McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features. J Clin Psychiatry. 2015; 76(4): 398-405.
37. Medda P, Toni C, Mariana MG, De Simone L, Mauri M, Perugi G. Electroconvulsive therapy in 197 patients with a severe, drugresistant bipolar mixed state: treatment outcome and predictors of response. J Clin Psychiatry. 2015; 76(9): 1168-1173.
38. Tohen M, McIntyre RS, Kanba S, Fujikoshi S, Katagiri H. Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5. J Affect Disord. 2014; 168: 136-141.
39. National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. Clinical Guideline [CG185]. London: National Institute for Health and Care Excellence; 2014. http://www.nice.org.uk/guidance/cg185/chapter/introduction
40. Ostacher MJ, Tandon R, Suppes T. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Bipolar Disorder: a novel, practical, patient-centered guide for clinicians. J Clin Psychiatry. 2016; 77(7): 920-926.
41. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015; 49(12): 1087-1206.
42. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. J Clin Psychiatry. 2009; 70(10): 1424-1431.
43. Fountoulakis KN, Kontis D, Gonda X, Siamouli M, Yatham LN. Treatment of mixed bipolar states. Int J Neuropsychopharmacol. 2012; 15(7): 1015-1026.
44. Muralidharan K, Ali M, Silveira LE, et al. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-Analysis of placebo-controlled trials. J Affect Disord. 2013; 150(2): 408-414.